Metabolic modes of action of the statins in the hyperlipoproteinemias

This publication has 30 references indexed in Scilit:

• Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature Pigs
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
• 1.P.178 Effect of atorvastatin on serum levels of lipoproteins in French Canadians with homozygous or compound heterozygous familial hypercholesterolemia
  Atherosclerosis, 1997
• Design and analysis of lipid tracer kinetic studies
  Current Opinion in Lipidology, 1996
• Simvastatin decreases the hepatic secretion of very‐low‐density lipoprotein apolipoprotein B‐100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications
  European Journal of Clinical Investigation, 1995
• Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia
  Journal of Internal Medicine, 1991
• Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: Lack of effect on low-density lipoprotein concentrations or turnover
  The Journal of Pediatrics, 1988
• Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1981
• Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
  FEBS Letters, 1976
• Receptor-Mediated Control of Cholesterol Metabolism
  Science, 1976